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Abstract
Background: Local inflammation may progress into systemic inflammation. To increase our understanding of the
basic immunological processes during transition of equine local inflammation into a systemic state, investigation
into the equine systemic immune response to local inflammation is warranted. Therefore, the aim of this study was
to investigate the innate peripheral blood leukocyte (PBL) immune response to local inflammation in horses, and to
compare this response with the PBL immune response during the early phase of acute systemic inflammation.
Expression of 22 selected inflammation-related genes was measured in whole blood leukocytes from 6 horses
in an experimental cross-over model of lipopolysaccharide- (LPS-) induced acute synovitis (3 μg LPS intraarticularly;
locally inflamed [LI] horses) and endotoxemia (1 μg LPS/kg intravenously; systemically inflamed [SI] horses). Multiple
clinical and hematological/biochemical examinations were performed, and serial blood samples were analyzed by
reverse transcription quantitative real-time PCR. Post-induction expression profiles of all genes were compared
between study groups using principal component analysis (PCA) and hierarchical clustering.
Results: Moderate synovitis and mild systemic inflammation of approximately 24 h duration was confirmed by
clinical and paraclinical observations in LI and SI horses, respectively. In the LI group, samples obtained 3–16 h
post-injection showed distinct clustering in the PCA compared with baseline levels, indicating a transcriptional
response to local inflammation in PBLs in this time interval. There was no clinical or hematological indication of
actual systemic inflammation. There was a clear separation of all LI samples from all SI samples in two distinct
clusters, indicating that expression profiles in the two study groups were different, independent of time since LPS
injection. Co-regulated genes formed four clusters across study groups which were distinctly differently regulated.
Only few of individual genes displayed different expression between the study groups at all times after LPS injection.
Conclusions: Local inflammation in horses initiated an innate transcriptional response in PBLs, which differed from the
transcriptional response during the early phase of systemic inflammation. This study may provide new insights into the
immunobiology of PBLs during the transition of local inflammation into a systemic state.
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Background
Acute inflammation denotes a series of generalized vas-
cular and cellular events that is induced by the innate
immune system in response to invading pathogens
and tissue trauma [1, 2]. Systemic inflammation arises
secondary to local inflammation if pro-inflammatory
substances such as pathogen-associated molecular pat-
terns (PAMPs), danger-associated molecular patterns
(DAMPs), and perhaps pro-inflammatory cytokines
are not successfully contained by local inflammatory
processes, and if these pro-inflammatory substances
overwhelm the initial systemic host defenses [1, 3, 4].
Activated peripheral blood leukocytes (PBLs), especially
neutrophil granulocytes and monocytes, and endothelial
cells are regarded key immunological cells in the initiation
and progression of systemic inflammatory processes [5, 6].
In the equine clinic, systemic inflammation is a fre-
quent sequela to diseases such as infectious colitis,
metritis, peritonitis, pleuropneumonia, and intrauterine/
neonatal infections [7]. There is however not always a
clear association between type of disease and the develop-
ment of systemic inflammation; some horses suffering
from local inflammation develop systemic inflammation
while others apparently do not. The importance of closely
monitoring patients at risk of developing systemic inflam-
mation is widely recognized, as rapidly initiated targeted
therapy is crucial to the treatment of systemic inflamma-
tory conditions [7, 8]. However, diagnosing early acute
systemic inflammation can be a challenge, as signs of dis-
ease during the transition of local inflammation into a sys-
temic state inevitably will contain a mix of host responses
to both local and systemic inflammatory processes. Also,
local inflammation may initiate clinical and paraclinical
signs which usually are thought of as evidence of systemic
involvement, even though systemic inflammation does not
appear to be present. This has been demonstrated in ex-
perimental studies of local inflammation in horses in
which alterations in body temperature, whole blood white
blood cell (WBC) count, and in some cases serum acute
phase reactants (APRs), were present in response to LPS-
induced synovitis [9–12] and E. coli-induced endometritis
[13]. A systemic response like this might be due to release
of locally produced pro-inflammatory cytokines to circula-
tion, as cytokines are well known initiators of both fever
[14], neutrophilia [15, 16], and acute phase responses [17].
Another, more indirect, source of such cytokines might be
PBLs and endothelial cells that are activated by pro-
inflammatory substances released from locally inflamed
tissues. From a clinical point of view, the most specific
sign of the early acute stage of systemic inflammation re-
gardless of cause seems to be the presence of pronounced
neutropenia [18], indicating that activated neutrophils
have marginated in the vasculature or have sequestrated
in the perivascular tissue on a generalized level [19, 20].
In human medicine, research into systemic inflamma-
tion is focused on complementing clinical and standard
paraclinical parameters with immunological markers to
optimize future diagnosis and prognosis of systemic in-
flammatory conditions [21, 22]. In both human and
equine research, the traditional way of investigating im-
mune processes during the onset of systemic inflamma-
tion is by quantitating inflammatory mediators in
serum or their corresponding gene expression in PBLs
in response to experimentally induced systemic inflam-
mation [23–27]. However, very little is known about
the systemic immune response to local inflammation.
To increase our understanding of basic immunological
processes during transition of equine local inflamma-
tion into a systemic state, investigation of the PBL im-
mune response to local inflammation is warranted.
Such investigations might further indicate if specific
PBL inflammatory mediators have a diagnostic poten-
tial in monitoring equine patients at risk of developing
systemic inflammation.
Therefore, the aim of this study was to investigate the
innate PBL immune response to local inflammation in
horses, and to compare this response with the innate
PBL immune response during the early phase of acute
systemic inflammation. This was done by measuring the
expression of 22 selected inflammation-related genes in
whole blood leukocytes in an equine cross-over model
of LPS-induced acute synovitis and endotoxemia. This
study is part of a larger experiment investigating inflam-
matory processes during equine LPS-induced acute
synovitis and endotoxemia. Clinical results and expres-
sion levels of single genes for the endotoxic horses have
previously been presented in Vinther et al. [28].
Methods
Horses
Six healthy, adult (7.7 ± 5.4 years), Danish Warmblood
or Danish Warmblood cross bred horses (2 geldings and
4 non-pregnant mares) with an initial body weight of
490 ± 39 kg were included in the study. The horses were
owned by the University of Copenhagen. Prior to the ex-
periment a full clinical examination and hematological
and biochemical analyses of blood and radiocarpal
synovial fluid were performed, and only horses without
clinical or hematological/biochemical signs of acute or
chronic inflammation [29] were included in the study.
All horses were dewormed with ivermectin (Maximec®)
and vaccinated against equine influenza and tetanus
(ProteqFlu-Te®) prior to the study. Approximately 2 weeks
before initiation of the study, horses were housed at the
research station in individual 3 x 4 m box stalls, where
they were fed an equine commercial grain mixture twice
daily and had access to water and hay ad libitum.
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Experimental design
A cross over study involving experimentally induced
endotoxemia and lipopolysaccharide-(LPS) induced
synovitis as models for systemic and localized inflam-
mation, respectively, was performed. Horses were ran-
domly assigned to start in one of the two study groups,
and the experiments were performed simultaneously on
one horse from each study group at a time. All horses
had an acclimatization period in the climate controlled
experimental facilities (maintained at a temperature of
12 ± 1 °C) of 5 days before initiation of the experiment.
To eliminate possible effects of LPS tolerance there was
a 4 week wash out period in between treatments [30].
LPS was derived from Escherichia coli strain 055:B5
(#L2880, Sigma-Aldrich Denmark). Using a polyureth-
ane jugular catheter (Milacath®, 14G, 150 mm), endo-
toxemia was induced over one minute with 1 μg/kg
LPS diluted in isotonic saline (Baxter A/S, Denmark) to
a total volume of 15 mL (systemically inflamed [SI]
horses). Synovitis was induced in the left carpal joint by
sterile intraarticular injection (Eickinject®, 21G, 40 mm)
of 3 μg LPS diluted in 1 mL Ringer’s Acetate (Baxter A/
S, Denmark) (locally inflamed [LI] horses). The LPS
doses were established on the basis of the biological ac-
tion of this particular batch of LPS in previous experi-
ments, where the 3 ug per joint dose resulted in a
clinically moderate but fully reversible synovitis that
lasted for approximately 24 h, and the IV dose of 1 ug/kg
resulted in a systemic inflammation with fully revers-
ible clinical signs of inflammation that lasted for ap-
proximately 24 h. Due to intraarticular LPS injection
failure in one LI horse, this group only consisted of
5 horses.
Clinical examinations
Examinations comprising general condition, rectal
temperature (RT), heart rate (HR), respiratory rate (RR),
mucosal membrane color, capillary refill time (CRT),
and lameness score (LI horses only) were performed
multiple times during the 24-h experimental period for
both SI and LI horses (Additional file 1). Lameness was
assessed independently by two observers using the
AAEP lameness score [31]. Two hours after intraarticu-
lar LPS injection the left carpal joint of the LI horses
was evaluated for swelling and heat, and synovial fluid
total protein and WBC were measured. 2.2 mL of syn-
ovial fluid was obtained by aseptic arthrocentesis
(EDTA tubes, BD Company), and synovial fluid total
protein and WBC was measured by use of a refractom-
eter1 and a haemocytometer2, respectively. Additional
arthrocenteses at post-injection hour (PIH) 4, 8, 16,
and 24 were performed as part of a study without rele-
vance for this experiment.
Blood sampling
Dependent on specific requirements for analyses at each
time point for sampling, 7.5–31.5 mL of blood was col-
lected in syringes (Kruuse) through the indwelling
jugular venous catheter and immediately transferred to
the appropriate blood tubes. The first 5 mL of blood
were drawn in a separate syringe and discarded. Base-
line samples (PIH 0) were taken immediately before
LPS injection. Blood for WBC and total neutrophil
granulocyte and lymphocyte counts was collected in
EDTA tubes (BD Company) at PIH 0, 1, 2, 3, 4, 6, 8, 12,
16, 20, and 24. Blood for APRs was collected in serum
tubes (serum amyloid A (SAA), haptoglobin, iron) or
citrate tubes (fibrinogen) (BD Company) at PIH 0, 2, 4,
8, 16, and 24. SAA was measured by immunoturbido-
metry3. Haptoglobin was measured by a biochemical
peroxidase assay in duplicate4. Iron was measured by
colorimetric spectrophotometry5. Fibrinogen was mea-
sured by the Clauss method in an automated coagulo-
metric analyzer6. A standardized volume of 2.5 mL of
blood for RNA extraction was collected in PAXgene
Blood RNA Tubes (Qiagen/BD Company), which allows
for later recovery of total RNA from all cells presents
in the blood sample. According to the manufacturer’s
instruction PAXgene™ blood tubes were gently inverted
8–10 times after sampling and kept at room
temperature for 2 to 24 h, before storage at -80 °C until
RNA extraction. Samples from LI horses were collected
at PIH 0, 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, and 24. For SI
horses, genes of interest were previously found to be
maximally differentially expressed within the first 8 h
after LPS injection [28]. Thus, only SI samples for PIH
1-8 were included in this study, serving as references
for the expression profiles during acute systemic in-
flammation in these particular horses.
Target genes
Relative gene expression in PBLs was measured by
quantification of specific mRNA for the following 22
genes: IL1B, IL6, IL8, IL10, IL15, IL17, IL18, IL1RN,
TNF, TLR4, CD14, ITGAM, ITGAX, SELL, MAPK14,
CASP3, BCL2L1, MMP8, TIMP1, IL6ST, CCL5, and
SOD2 (Additional file 2). As presented in Vinther et al.
[28]; these 22 genes were significantly regulated in the
SI horses at one or more time points during the first
8 h after intravenous LPS injection. Significant regula-
tion was defined as a statistically significant change in
gene expression of at least 2.5 fold compared with base-
line levels.
RT-qPCR
Total RNA extraction and quality analysis, cDNA syn-
thesis, specific primer design, pre-amplification and exo-
nuclease treatment, and qPCR were performed as
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previously described [28]. Briefly, total cellular RNA
was extracted from PAXgene™ blood samples using
PAXgene Blood miRNA Kits (Qiagen/BD Company)
and treated with RNase-Free DNase sets (Qiagen/BD
Company). Concentration and purity of total extracted
RNA was determined by spectrophotometric analyses7.
Samples containing less than 20 ng RNA/μL were evap-
orated (37 °C) to increase RNA concentration using a
SPD111V SpeedVac Concentrator8. RNA integrity was
estimated using an Agilent 2100 Bioanalyzer9 and RNA
6000 Nano Kits (Agilent Technologies). Each total
RNA sample was assigned an RNA Integrity Number
(RIN) from 1-10, with 10 being non-degraded RNA
[32]. Mean RIN value ± SD of all samples was 8.9 ± 0.9.
After extraction RNA was DNase treated a second
time and 300 ng of total RNA per sample converted into
first-strand cDNA by reverse transcription using a Tpro-
fessional TRIO 3x4810 and QuantiTect Reverse Tran-
scription Kits (Qiagen/BD Company) according to the
manufacturer’s instructions. For assay validation, two
separate cDNA replicates were performed for each RNA
sample and a non-reverse transcriptase control was in-
cluded. The cDNA samples were diluted (1:7.7) in low
TE-buffer (VWR-Bie & Berntsen) and stored at -20 °C
until pre-amplification procedures.
Gene specific primer pairs were designed as previously
described [28] and synthesized at TAG Copenhagen
(Denmark) or Sigma-Aldrich (Denmark). Transcript IDs,
primer sequences, amplicon lengths, reaction efficiencies,
and correlation coefficients are shown in Additional file 2.
Primer amplification efficiencies, correlations and dy-
namic ranges were acquired from standard curves based
on 4 separate dilution series (3 representing the whole
sample material and 1 representing samples with high
levels of IL6 to specifically meet the dynamic range of this
particular gene) of pooled cDNA [28]. Efficiencies be-
tween 0.91 and 1.12 and correlations above 0.97 were
accepted.
Stocks of 200 nM primer pair mix in low TE-buffer
(VWR-Bie & Berntsen, Denmark) were prepared com-
bining equal amounts of all primers used in the study.
Primer pair mix, TaqMan PreAmp Master Mix (Applied
Biosystems), and cDNA were mixed and incubated at
95 °C for 10 min followed by 16 cycles of 95 °C for 15 s
and 60 °C for 4 min. After pre-amplification cDNA was
exonuclease treated. An aliquot of the pre-amplified
cDNA was saved for preparation of dilution series, and
finally cDNA was diluted in low TE-buffer before quan-
titative real-time PCR (qPCR).
Quantitative PCR was performed in 48.48 Dynamic
Array Integrated Fluidic Circuits (IFC) on a BioMark
Fluidigm thermocycler11 combining 48 samples with 48
primer sets in 2304 separate, simultaneous reactions
[33]. Each chip included a non-template control (NTC),
a non-reverse transcriptase control, and cDNA dilution
pools. Expression data (Cq values in heat maps) and
melting curves were acquired using Fluidigm Real-Time
PCR Analysis software 3.0.2 (Fluidigm). NTCs and melt-
ing curves were used to monitor for non-specific ampli-
fication or sample contaminations, and non-reverse
transcriptase controls were used to assess potential
DNA contamination. For both of these control samples,
a minimum of 5 Cq-values between potential signals and
a given sample signal were required, and only genes with
a single melting peak (within 1 °C) were accepted for
further data analyses.
Pre-processing and quantification of data
Expression data were exported to GenEx512 for pre-
processing and quantification. Dilution pools were used
as inter plate calibrators. Data was corrected for primer
efficiencies for each primer assay individually. Using
NormFinder [34] and GeNorm [35] the most stably
expressed reference genes (ACTB, TBP, DIMT1, SDHA,
HPRT1, and B2M) out of 7 putative candidates were se-
lected for normalization. cDNA technical replicates were
averaged. Finally, relative expression levels were estab-
lished. For each gene of interest the expression level was
set to 1 for the sample with the lowest level of expres-
sion. Expression levels for the specific gene of interest in
all other samples irrespective of horse and time for sam-
pling were then calculated relative to this sample during
data transformation from Cq (log2) to relative quantities
(relative fold change, linear scale).
Statistical analyses
Clinical and paraclinical data
Clinical and paraclinical data are presented as mean
values except for lameness score, which is presented as
a range of scores of individual horses. Selected clinical
and paraclinical data are depicted graphically using Sig-
maPlot v. 12.5. Statistical analyses of selected clinical
and hematological responses (RT, HR, RR, WBC
counts, APRs) were analyzed with a two-way ANOVA
random effect (mixed effect) model (R v. 3.1.2) where
time and treatment (and their interaction) were fixed
effects that influence the mean. A serial Gaussian cor-
relation structure was included to allow for time-
dependent correlation within each treatment on each
horse and to allow for variation among horses. Distri-
bution of data was evaluated by residual plots and data
was log2-transformed to improve the model fits. The t-
test was used to compare each time point with the
baseline at PIH 0 and to compare time points between
treatments groups (APRs only). The Bonferroni correc-
tion was used to account for testing multiple disease
parameters, and statistical significance was defined as
P < 0.0063 (significance level 0.05/8 parameters). No
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correction was made for testing at multiple time points
as number of time point varied between parameters.
Expression data
All analyses on expression data were performed on log2-
transformed, autoscaled data using GenEx5. Data was
autoscaled to have similar weights in the analyses re-
gardless of magnitude and variation in expression levels
of the 22 genes [36]. To disclose multivariate responses
in the study groups, the method of principal component
analysis (PCA) was employed, grouping samples or
genes based on gene co-expression patterns [37]. In the
present study, two PCAs were performed to visualize
clusters of individual samples. The first PCA included
expression data of all LI samples divided into the follow-
ing subgroups: PIH 0, PIH 1-2, PIH 3-4, PIH 5-8, PIH
10-16, and PIH 20-24. The second PCA included ex-
pression data of SI (PIH 1-8) samples, LI (PIH 3-16)
samples, and baseline samples for both study groups.
Based on expression level group means, differences in
expression profiles of LI (PIH 3-16) samples in relation
to SI (PIH 1-8) samples were further visualized in a heat
map combining dendrograms of samples and genes. The
dendrograms were performed by using agglomerative
clustering, Euclidean distance as the distance measure
and Ward’s method as clustering algorithm.
Results
Clinical and paraclinical responses to endotoxin
During the acclimatization period all horses were
bright, alert, and responsive, and considered healthy on
clinical and hematological examinations (data not
shown). A graphical presentation of baseline and post-
injection results of selected clinical and paraclinical pa-
rameters including statistics for both study groups are
presented in Figs. 1 and 2. SI horses started to show
signs consistent with endotoxemia such as anorexia,
mild to moderate colic, fever, tachycardia, and pro-
nounced neutropenic leukopenia within the first two
hours post-injection. WBC started to increase after PIH
2 due to an increasing number of circulating neutrophil
granulocytes, and at PIH 4 rectal temperature peaked.
Within the first 8 h after LPS injection all horses except
one had hyperemic, dark red, or cyanotic mucosal
membranes and a CRT of 3–4 s. At PIH 8, a mildly ele-
vated rectal temperature and heart rate, an increasing
WBC count, decreased appetite, depression, and mild
colicky behavior characterized the clinical status. After
24 h horses had an elevated heart rate and WBC count
but were all, except for one horse, bright, alert, and re-
sponsive. All horses recovered without treatment.
At PIH 2, LI horses were 4 to 5° lame (5° scale), and
had mild tachycardia and tachypnea (Fig. 1). There was
swelling of the left carpal joint, palpable heat, and
elevated synovial fluid total protein (35.2 ± 9.7 g/L) and
WBC count (61.2 ± 31.6 x 109 cells/L) (reference values
of non-inflamed synovial fluid total protein and WBC
approximately 0.2 g/L and 87-167 x 106 cells/L, respect-
ively [38]). During the following 2–6 h horses expressed
varying degrees of depression, decreased appetite, mild
colic, increased WBC counts, tachycardia, and tachypnea.
Rectal temperature was slightly elevated at PIH 5-12.
Lameness score was 4 to 5° at PIH 8. At PIH 24, horses
were 1 to 3° lame and were bright, alert, and responsive.
During the entire disease period all horses had a nor-
mal mucosal membrane color and CRT ≤ 2 s. None of
the horses received analgesic treatment at any time
during the study.
As seen in Fig. 2, serum SAA concentration for SI
horses increased from 8 h post-injection until the end of
the study whereas for LI horses SAA levels increased at
16 and 24 h of the onset of the study. Iron concentration
was decreased after 16 h for both groups. In the LI
group, haptoglobin and fibrinogen concentration was in-
creased at PIH 24, while no significant changes were
seen for these two acute phase proteins in the SI group.
SAA concentration was different between SI and LI
horses at PIH 8. Otherwise acute phase proteins did not
differ between study groups within the 24-h observa-
tional period.
Expression analyses
In the two study groups PCA was used to investigate the
innate gene expression response in PBLs based on co-
expression patterns of individual samples. Figure 3a and
b were obtained by plotting all relevant samples by their
two first principal components obtained from all 22
genes. Figure 3a shows distinct clustering of samples
from LI (PIH 3-4), LI (PIH 5-8), and to a certain extend
LI (PIH 10-16) horses compared with baseline samples.
Figure 3b includes all samples from SI horses (PIH 1-8)
together with the samples from LI horses in which co-
expression patterns in Fig. 3a showed distinct clustering
from baseline samples (PIH 3-16). There was a distinct
clustering of SI samples from LI samples regardless of
time since LPS injections. This clustering was not seen
in baseline samples before LPS injection. All samples
from SI horses clustered separately from pre-injection
samples.
A heat map combining two dendrograms was con-
structed to visualize the expression matrix of samples
and genes together to further characterize clustering
within samples and genes for SI (PIH 1-8) horses and
LI (PIH 3-16) horses based on average expression
levels (Fig. 4). As seen in the upper dendrogram,
samples grouped in three main clusters: SI (PIH 1-3),
SI (PIH 4-8), and LI (PIH 3-16). The response levels
of genes, going from green (low expression) to red
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Fig. 1 (See legend on next page.)
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(high expression) were more pronounced and fluctu-
ating for the SI group. Genes clustered in 4 groups
with similar expression patterns (Cluster A-D) across
study groups. The genes IL8 and IL1RN and to a
lesser degree IL1B in Cluster C were transcribed to
different levels for SI and LI horses independent of
time since injection of LPS. Expression levels of all
other genes only differed between SI and LI horses in
certain time intervals during the two disease courses.
In the SI group, gene expression levels in Cluster A
(IL18 to TIMP1) increased from low to high over
time, having a markedly different level than those of
the LI horses at PIH 1-2 and PIH 5-8, but not at PIH
3-4. Genes in Cluster B (IL15, CD14, MAPK14,
ITGAM) showed different expression levels between
the LI group and the first 3 h post-injection for the SI
group. Genes in Cluster D (IL10, TNF, IL17, IL6, CCL5)
were most highly expressed during the first hours in
the SI group but otherwise showed heterogeneous tran-
scription patterns.
(See figure on previous page.)
Fig. 1 Clinical and hematological responses to LPS. Rectal temperature, heart rate, respiratory rate, white blood cell (WBC) counts, and neutrophil
granulocyte/lymphocyte ratio in horses with induced systemic (red) and local (blue) inflammation, respectively. All values except neutrophil
granulocyte/lymphocyte ratio are depicted as mean ± SD. Asterisk (*) denotes statistical significant differences compared with baseline levels
at PIH 0 (P < 0.0063). Please note that clinical and hematological responses for the horses with systemic inflammation have also been presented in the
article Vinther et al. [28]. PIH: post-injection hour
Fig. 2 Acute phase responses to LPS. Concentration of serum or plasma serum amyloid A (SAA), haptoglobin, fibrinogen, and iron (mean ± SD) in
horses with induced systemic (red) and local (blue) inflammation, respectively. Asterisk (*) denotes statistical significant differences compared with
baseline levels at PIH 0, while hash tag (#) denotes statistical significant differences between SI and LI horses (P < 0.0063). PIH: post-injection hour
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Fig. 3 Clustering of samples from systemically and locally inflamed horses. Clustering of samples based on the co-expression patterns of 22 innate
genes measured in PBLs. Clustering was performed by use of principal component analysis (PCA) in which individual samples were plotted by
their two first principal components. a Expression data of all LI samples was divided into the following subgroups: PIH 0 (baselines), PIH 1-2, PIH
3-4, PIH 5-8, PIH 10-16, and PIH 20-24. Ellipses are drawn to highlight the sample subgroups at PIH 3-4, PIH 5-8, and PIH 10-16. b Expression data
of SI (PIH 1-8) samples, LI (PIH 3-16) samples, and baseline samples for both study groups. PIH: post-injection hour
Fig. 4 Expression matrix of samples and genes from systemically and locally inflamed horses. Mean expression data for SI (PIH 1-8) samples and
LI (PIH 3-16) samples for each of the 22 genes visualized in a heat map. Relative expression levels are visualized by color intensities where red
corresponds to high expression and green corresponds to low expression. Please note that baseline samples are not included to indicate baseline
levels. The upper dendrogram shows clustering of samples across genes. The dendrogram to the left indicates clustering of genes across samples
(time points and study groups). Clustering is based on similarities between samples/genes indicated by the distance at which they are joined.
Short distance indicates high similarity. PIH: post-injection hour
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Discussion
All horses in the SI and LI group developed classic signs
of mild endotoxemia and moderate aseptic synovitis, re-
spectively, and both clinical disease courses were self-
limiting and lasted approximately for the expected 24 h.
In addition to local inflammation and pain, LI-horses
showed the systemic response of fever, increased periph-
eral blood WBC counts, and alterations in serum acute
phase reactants previously described in other studies of
equine induced local inflammation [9–11], clinically
indicating the systemic presence of pro-inflammatory
cytokines [14–17]. A hallmark of acute systemic in-
flammation is the activation of the endothelium, lead-
ing to expression of adhesion molecules and leukocyte
margination [5]. This is clinically reflected by a rapidly
initiated marked decrease in circulating leukocytes,
which could be appreciated in the SI horses as early as
one hour after induction of inflammation. In contrast,
this hallmark of early systemic inflammation was not
detected at any time point in the LI horses (Fig. 1). As
all other vital clinical and hematological disease pa-
rameters, except for RR, in the LI horses only changed
mildly, there is a strong indication that intraarticular
LPS injection in these horses had not elicited second-
ary systemic inflammation.
Figure 3a reveals that samples LI (PIH 3-4) and LI
(PIH 5-8) clustered distinctly from baseline samples,
while LI (PIH 10-16) samples clustered with a partial
overlap to baseline samples. This indicates changes in
transcription of innate immune genes in circulating leu-
kocytes approximately 3–16 h after intraarticular LPS in-
jection. To our knowledge, this study is the first in
horses to show that LPS-induced local inflammation can
initiate a complex transcriptional response of innate im-
mune genes in circulating leukocytes. As the horses by
all appearances did not experience actual systemic in-
flammation, this further implies that the detection of
transcription activity of innate inflammatory mediators
in circulating leukocytes not necessarily equals a sys-
temic inflammatory process in an individual. Whether
the systemic response of fever, increased WBC count,
and changes in serum APR concentration was due to the
release of pro-inflammatory cytokines from the inflamed
joint, or whether it was mediated by cytokines produces
by activated PBLs, is unknown. However, the increase in
WBC count and rectal temperature was not detectable
until after the transcriptional onset of genes in PBLs, in-
dicating a relationship between these signs of disease
and activation of PBLs. In contrast to this, there was no
PBL transcriptional response in LI horses at PIH 2,
where horses were almost non-weight-bearing lame, had
mild tachycardia and tachypnea, and had signs of acute
joint inflammation such as local swelling and heat and
elevated synovial fluid total protein and WBC count.
This clinical presentation thus reflected a purely local in-
flammatory process where tachycardia and tachypnea
may have been responses to pain from the inflamed joint
[39]. Our results thus suggest that elevated body
temperature and an increased WBC count may be more
indicative of the presence of innate inflammatory media-
tors in circulation than tachycardia and tachypnea. How-
ever, WBC was still significantly elevated at PIH 20
where the systemic expression response had abated.
The presence of inflammatory mediators in circulation
in response to local inflammation has only been sparsely
investigated in horses. In Cook et al. [40], increased
serum levels of the lipid mediators prostaglandin E2
and thromboxane B2 were found after ischemia-
induced local inflammation of the jejunum, and in a
study by Campebell et al. [11], no difference in serum
TNF-a concentration could be detected in LPS-induced
synovitis despite significant changes in body temperature
and circulating white blood cell composition in response
to LPS. In induced endometritis in mares, transcription of
the cytokines IL1B, IL6, IL8, IL10, TNF, and IL1RN were
investigated in serial samples after inflammatory induc-
tion, but no differences were found when compared with
pre-induction levels [41]. In dogs, mild changes in WBC
counts and in markers of coagulation (activated partial
thromboplastin time, fibrinogen, protein-C, and -S) were
seen in peripheral blood in response to experimentally in-
duced localized soft tissue inflammation [42]. Increased
levels of for example serum IL-6, IL-10, and HMGB-1
were reported in pigs and mice in more severe models of
local inflammation such as multiple trauma [43, 44] and
acute kidney injury [45]. Even though the exact mecha-
nisms determining whether local inflammation is strictly
contained, mediates a systemic response, or initiates actual
systemic inflammation are unknown, the severity of the
initial insult is probably an important factor. A general
dose dependency of the in vivo response to LPS has previ-
ously been shown in an experimental study in cattle [46].
Furthermore, a study on equine LPS-induced synovitis by
Palmer and Bertone [10] specifically supports a dose de-
pendency in the transition of local inflammation to a sys-
temic state, as signs of systemic involvement (fever,
altered leukocyte differential count) were only observed
after high intraarticular injection doses of LPS. Factors
such as pathogen virulence [47, 48] and immune compe-
tence of the host [49, 50] most likely contribute to deter-
mine the outcome of local inflammation.
In the present study, the PBL transcriptional response
to local inflammation at PIH 3-16 was compared with
the PBL transcriptional response during the early phase
of acute systemic inflammation. The clear separation of
all LI samples from all SI samples (Fig. 3b) indicates that
expression profiles in the two study groups were sub-
stantially different independent of time since LPS
Vinther et al. BMC Veterinary Research  (2016) 12:83 Page 9 of 13
injection. In this study, expression profiles of innate
immune genes in circulating leukocytes could thus dif-
ferentiate horses with systemic inflammation from
horses with local inflammation and a secondary sys-
temic transcriptional response, during both onset and
progression of inflammation. For comparison, pro-
nounced leukopenia, which is pathognomonic for sys-
temic inflammation, was only seen in SI horses for
approximately 4 h (Fig. 1). Like WBC, the APRs SAA,
haptoglobin, fibrinogen, and iron are also widely used
in the diagnosis of inflammation in both veterinary
and human medicine [17, 51–53]. While transcription
of leukocyte genes in the present study could be de-
tected within the first few hours after LPS injection in
both study groups, the acute phase reactants did not
significantly change until PIH 8 at the earliest. A delay
in acute phase responses compared with cytokine re-
sponses is not surprising as cytokines are well known
mediators of APRs [17]. It was however remarkable
that the 24-h acute phase responses were similar be-
tween SI and LI horses despite the two distinctly dif-
ferent gene expression profiles.
To further characterize differences in the PBL tran-
scriptional responses in the two study groups, a heat
map combining two dendrograms was constructed using
mean expression values for horses for SI (PIH 1-8) and
LI (PIH 3-16) samples (Fig. 4). Color intensities in the
heat map suggest that the expression response for the SI
group in general was more pronounced and with greater
fluctuations than for the LI group. This may also be ap-
preciated by the scattered cluster of individual SI sam-
ples and the much tighter cluster of individual LI
samples in Fig. 3b. The clustering of study groups seen
in Fig. 3b is supported by the upper dendrogram in
Fig. 4, which furthermore suggests subgrouping of SI
samples in PIH 1-3 and PIH 4-8. The subgrouping of SI
samples indicates a marked change in the expression
profile for SI horses as the disease course progressed,
which was likely due to the transition from relative lym-
phocytosis to relative neutrophilia. The dependence of
gene expression results upon the composition of the
various types of white blood cells is supported by both
equine [54] and human [55, 56] studies and is for the
present experiment discussed in detail in Vinther et al.
[28]. The heat map suggests that especially IL6, IL17,
and most of the genes in Cluster A contributed to sub-
grouping of the inflammatory response in the SI group.
The 22 genes included in the study clustered in four
main groups based on their temporal expression pat-
terns (Cluster A-D, Fig. 4). Grouping of the genes IL8,
IL1RN, and IL1B (Cluster C) was also seen in a study by
Prabhakar et al. [57], in which 16 different genes were
clustered by similarities in time profiles during a 24-h
course of human LPS-induced systemic inflammation.
In the present study, genes within especially Cluster A
and B tended to follow the same expression pattern in
the SI group, which indicates that the panel of genes
could probably be reduced within these clusters without
affecting the overall clustering analyses. Assessed visu-
ally, only few of the specific genes displayed distinctly
different expression levels between study groups, irre-
spective of time since LPS injection. Except for IL8,
IL1RN, and IL1B which seemed to be consistently higher
expressed in SI-horses, single gene expressions thus only
discriminated LI samples from SI samples in certain
time intervals. IL1RN has not previously been investi-
gated in systemic inflammation in the horse, and while
IL8 and IL1B seem to be differentially expressed in
equine experimental systemic inflammation [25, 27, 58],
the transcriptional response of these genes in equine
septic patients is more unclear [54, 59–61].
By evaluating expression profiles across the 22 genes
instead of expression levels of each gene one by one, a
more detailed and comprehensive picture of the com-
plex immunological states of the cells was obtained.
Multivariate methods for analysis such as PCA and hier-
archical clustering are not frequently used in studies of
innate immune gene expressions in large animals even
though the well described interactions of inflammatory
mediators [23, 62] make it a biologically relevant ap-
proach. Theoretically, the optimal experimental model
to study innate immune processes during the transition
of local inflammation into a systemic state would be a
model in which systemic inflammation was obtained by
inducing local inflammation. To our knowledge, no such
experimental model is however well characterized in the
horse and we therefore used the traditional intra-
articular LPS model as a model for a localized inflamma-
tion, even though this may not be the most frequent
source of a systemic inflammation. Another limitation of
the study includes the fact that the group of horses was
quite different according to gender, age, and origin. Fur-
thermore, the complete clinical history of the horses
prior to the inclusion examinations was not known, leav-
ing questions on possible endotoxin tolerance due to
previous endotoxin related diseases. However, none of
the experimental horses showed a decreased pyrogenic
response or lack of illness behavior, which are consid-
ered clinical hallmarks of tolerance [30, 63]. Addition-
ally, induced in vivo endotoxin tolerance in horses
subsides within 2-3 weeks [30], meaning that the risk of
endotoxin tolerance in the experimental horses was low.
The 4 week wash out period between the two challenges
reduced the risk of induction of endotoxin tolerance,
and the cross over study minimized effects of the large
individual variation known to characterize the innate im-
mune response [55, 64, 65]. The clear clustering of genes
described here therefore represent robust findings,
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despite the low number of experimental horses and their
different backgrounds. In the present study, by restrict-
ing samples in the SI group to the first 8 h after LPS in-
jection, this model of systemic inflammation was
representative of the expression profiles during the onset
and progression of early systemic inflammation. Since
there is very little knowledge of the possible PBL re-
sponse to local inflammation, samples from LI horses
were included covering the complete course of disease
from clinical onset to approximate recovery (PIH 1-24).
To our knowledge, this is the first study in horses that
specifically assesses the PBL transcriptional response to
local inflammation and describes it in the context of on-
set and early development of systemic inflammation.
New insights into the molecular mechanisms involved in
the transition of local inflammation into a systemic state
is needed for future advances in the diagnostic oppor-
tunities of early systemic inflammation in horses. A re-
cent study by Hooijberg et al. [66] highlights the need
for this to supplement standard clinical and paraclinical
parameters in the differentiation of equine local and sys-
temic inflammation. The study retrospectively investi-
gated the diagnostic efficacy and combined predictive
capability of the myeloperoxidase index (MPXI), and
plasma fibrinogen, iron, and SAA concentrations for the
diagnosis of systemic inflammation, local inflammation,
or non-inflammatory disease in hospitalized horses.
Based on quantitative results of these markers, diagnos-
tic guidelines could not be formulated by Hooijberg and
colleagues. The group of systemically inflamed horses in
the study did not specifically represent early systemic in-
flammation, but given the results of the APRs in the
present study this might not have changed the conclu-
sion. In the present study, an important finding with dir-
ect clinical implication is the fact that self-limiting,
moderate, local inflammation of brief duration mediated
transcription of inflammation-related genes in PBLs.
This suggests that a substantial part of equine patients
with local inflammatory conditions are exposed to in-
flammatory mediators on a systemic level, emphasizing
the relevance of close monitoring of this patient group.
Conclusions
The results in this study showed that LPS-induced local
inflammation in horses could initiate a transcriptional
response of inflammation-related genes in circulating
leukocytes, and that such a response not necessarily
equals a systemic inflammatory process in the individual.
The co-expression patterns of multiple genes differenti-
ated horses with a systemic transcriptional response to
local inflammation from horses with early systemic in-
flammation, independent of the progression of inflam-
matory states. Only few of the individual genes displayed
distinctly different expression levels between study groups
irrespective of time since LPS injection. This study may
provide new insights into the immunobiology of PBLs
during the transition of local inflammation into a systemic
state and encourage further research in the subject.
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